|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
Calcium Hydroxide results in increased expression of ALPL mRNA |
CTD |
PMID:22083529 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
Calcium Hydroxide results in increased expression of COL1A1 mRNA |
CTD |
PMID:22083529 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Esr1 |
estrogen receptor 1 |
increases expression |
ISO |
Calcium Hydroxide results in increased expression of ESR1 mRNA |
CTD |
PMID:22083529 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
affects expression |
ISO |
Calcium Hydroxide affects the expression of POLG mRNA |
CTD |
PMID:30615914 |
|
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
|
|
G |
Polg2 |
DNA polymerase gamma 2, accessory subunit |
affects expression |
ISO |
Calcium Hydroxide affects the expression of POLG2 mRNA |
CTD |
PMID:30615914 |
|
NCBI chr10:91,712,586...91,723,008
Ensembl chr10:91,712,586...91,723,008
|
|
G |
Tfam |
transcription factor A, mitochondrial |
affects expression |
ISO |
Calcium Hydroxide affects the expression of TFAM mRNA |
CTD |
PMID:30615914 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
increases expression |
ISO |
Calcium Hydroxide results in increased expression of TRPV1 mRNA |
CTD |
PMID:22083529 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
[Aluminum Hydroxide co-treated with Magnesium Hydroxide] promotes the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine results in increased activity of CASP1 protein]; [Aluminum Hydroxide co-treated with Magnesium Hydroxide] promotes the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine results in increased expression of and results in increased secretion of CASP1 protein modified form]; CASP1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] |
CTD |
PMID:18604214 PMID:22075093 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
ISO |
Magnesium Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] |
CTD |
PMID:22750351 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
ISO |
Magnesium Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] |
CTD |
PMID:22750351 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
[Aluminum Hydroxide co-treated with Magnesium Hydroxide] inhibits the reaction [K-12 lipopolysaccharide results in increased secretion of CXCL10 protein] |
CTD |
PMID:17404311 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
[[Aluminum Hydroxide co-treated with Magnesium Hydroxide] co-treated with K-12 lipopolysaccharide] results in increased secretion of IL1B protein modified form; [Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein; CASP1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL1B protein] [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] co-treated with N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein; IL1R1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] |
CTD |
PMID:17404311 PMID:18604214 PMID:22075093 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
multiple interactions |
ISO |
IL1R1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] |
CTD |
PMID:18604214 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein; N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein]; TLR4 protein affects the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein]] |
CTD |
PMID:22075093 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] |
CTD |
PMID:18604214 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] |
CTD |
PMID:18604214 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
TLR4 protein affects the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein]]; TLR4 protein affects the susceptibility to [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] co-treated with N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine]; TLR4 protein affects the susceptibility to [Aluminum Hydroxide co-treated with Magnesium Hydroxide] |
CTD |
PMID:22075093 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
|
G |
Cfl1 |
cofilin 1 |
increases expression |
ISO |
potassium hydroxide results in increased expression of CFL1 mRNA; potassium hydroxide results in increased expression of CFL1 protein |
CTD |
PMID:21469165 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
multiple interactions increases expression |
ISO |
potassium hydroxide results in decreased expression of and affects the localization of HSPB1 protein potassium hydroxide results in increased expression of HSPB1 mRNA |
CTD |
PMID:21469165 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
potassium hydroxide results in increased expression of and results in increased secretion of IL1A protein |
CTD |
PMID:21469165 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression decreases expression |
ISO |
potassium hydroxide results in increased expression of SOD1 mRNA potassium hydroxide results in decreased expression of SOD1 protein |
CTD |
PMID:21469165 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions increases expression |
EXP |
lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of ACTA2 protein] |
CTD |
PMID:38202631 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP |
Sodium Hydroxide results in increased expression of CASP3 mRNA lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of CASP3 mRNA] |
CTD |
PMID:38202631 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
increases expression multiple interactions |
EXP |
Sodium Hydroxide results in increased expression of COL1A2 protein lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of COL1A2 protein] |
CTD |
PMID:38202631 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions increases expression |
EXP |
lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of COL3A1 protein] |
CTD |
PMID:38202631 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Egfr |
epidermal growth factor receptor |
affects response to substance |
ISO |
EGFR SNP affects the susceptibility to Sodium Hydroxide |
CTD |
PMID:27206134 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ezr |
ezrin |
increases expression |
ISO |
Sodium Hydroxide results in increased expression of EZR mRNA |
CTD |
PMID:29893927 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
Fn1 |
fibronectin 1 |
increases expression multiple interactions |
EXP |
Sodium Hydroxide results in increased expression of FN1 protein lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of FN1 protein] |
CTD |
PMID:38202631 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Ier3 |
immediate early response 3 |
affects response to substance |
ISO |
IER3 SNP affects the susceptibility to Sodium Hydroxide |
CTD |
PMID:27258892 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
Sodium Hydroxide results in increased expression of IL1B protein |
CTD |
PMID:29953848 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il22 |
interleukin 22 |
affects response to substance |
ISO |
IL22 SNP affects the susceptibility to Sodium Hydroxide |
CTD |
PMID:27206134 |
|
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
EXP |
Sodium Hydroxide results in increased expression of JUN mRNA lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of JUN mRNA] |
CTD |
PMID:38202631 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnk3 |
potassium two pore domain channel subfamily K member 3 |
increases activity decreases response to substance |
ISO |
Sodium Hydroxide results in increased activity of KCNK3 protein KCNK3 protein mutant form results in decreased susceptibility to Sodium Hydroxide |
CTD |
PMID:30365877 |
|
NCBI chr 6:25,761,487...25,799,153
Ensembl chr 6:25,763,228...25,799,153
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
increases expression multiple interactions |
EXP |
Sodium Hydroxide results in increased expression of MMP9 mRNA lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of MMP9 mRNA] |
CTD |
PMID:38202631 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Plau |
plasminogen activator, urokinase |
affects response to substance |
ISO |
PLAU SNP affects the susceptibility to Sodium Hydroxide |
CTD |
PMID:27206134 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
affects response to substance |
ISO |
HLA-G SNP affects the susceptibility to Sodium Hydroxide |
CTD |
PMID:27258892 |
|
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
|
|
G |
Trim10 |
tripartite motif-containing 10 |
affects response to substance |
ISO |
TRIM10 SNP affects the susceptibility to Sodium Hydroxide |
CTD |
PMID:27258892 |
|
NCBI chr20:1,689,554...1,698,948
Ensembl chr20:1,689,562...1,698,252
|
|
G |
Trim31 |
tripartite motif-containing 31 |
affects response to substance |
ISO |
TRIM31 SNP affects the susceptibility to Sodium Hydroxide |
CTD |
PMID:27258892 |
|
NCBI chr20:1,653,165...1,666,494
Ensembl chr20:1,653,165...1,666,494
|
|
G |
Trim40 |
tripartite motif-containing 40 |
affects response to substance |
ISO |
TRIM40 SNP affects the susceptibility to Sodium Hydroxide |
CTD |
PMID:27258892 |
|
NCBI chr20:1,676,114...1,685,906
Ensembl chr20:1,676,270...1,685,214
|
|